0001144204-19-029513 Sample Contracts

OUTLOOK THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [·], 20__ Debt Securities

Indenture • June 3rd, 2019 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Indenture
• Filed
  June 3rd, 2019
• Company
  Outlook Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

Indenture, dated as of [·], 20__, among Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):

Outlook Therapeutics, Inc. and _____________, As Warrant Agent Form of Preferred Stock Warrant Agreement Dated As Of __________

Preferred Stock Warrant Agreement • June 3rd, 2019 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Preferred Stock Warrant Agreement
• Filed
  June 3rd, 2019
• Company
  Outlook Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Preferred Stock Warrant Agreement (this “Agreement”), dated as of [●], between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Outlook Therapeutics, Inc. and _____________, As Warrant Agent Form of Common Stock Warrant Agreement Dated As Of __________

Common Stock Warrant Agreement • June 3rd, 2019 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Common Stock Warrant Agreement
• Filed
  June 3rd, 2019
• Company
  Outlook Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Common Stock Warrant Agreement (this “Agreement”), dated as of [●], between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).

Outlook Therapeutics, Inc. and _____________, As Warrant Agent Form of Debt Securities Warrant Agreement Dated As Of __________

Debt Securities Warrant Agreement • June 3rd, 2019 • Outlook Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Debt Securities Warrant Agreement
• Filed
  June 3rd, 2019
• Company
  Outlook Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between Outlook Therapeutics, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).